Hematologic Diseases Clinical Trials

170 clinical trials for Hematologic Diseases across international registries, including 22 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Long-term Follow-up Study in Participants Who Received CTX001 — RECRUITING · PHASE3
• Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors — RECRUITING
• The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease — RECRUITING · NA
• Autologous Testicular Tissue Transplantation — RECRUITING · NA
• Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease — RECRUITING · PHASE3
• Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes — RECRUITING · NA
• Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback — RECRUITING · PHASE1
• Bone Marrow Grafting for Leukemia and Lymphoma — RECRUITING
• IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia — RECRUITING · PHASE1
• HEME Home Transfusion Program — RECRUITING · NA
• CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases — RECRUITING · PHASE1
• Visual and Auditory Distraction for the Relief of Pain and Anxiety — RECRUITING · NA
• Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults — RECRUITING · NA
• The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research — RECRUITING
• Study on the Clinical Efficacy of Teclistamab — RECRUITING
• The Interplay Between Inborn Error of Immunity and Blood Disorders: Unravelling Immune Defects Behind Common Haematological Diseases — RECRUITING · NA
• Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING · PHASE1
• Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study) — RECRUITING
• Clinical Study of Combined Platelet Transfusion — RECRUITING · PHASE4
• A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study — RECRUITING · PHASE1
• Naturopathic-pharmacological Consultation in Hematology — RECRUITING · NA
• Molecular Characterizazion and Biological Samples Centralisation of Patients Affected by Oncoematolofic Pathology — RECRUITING · NA
• Muscle Dysfunction in Patients With Haematological Diseases — ACTIVE_NOT_RECRUITING
• Bispecific CD19/CD20-Targeted Chimeric Antigen Receptor (CAR) Modified T Cells With 4-1BB and Mutated CD28 Costimulatory Domains in Patients With Relapsed or Refractory CD19+ Hematologic Malignancies — NOT_YET_RECRUITING · PHASE1
• Gulf Long-Term Follow-Up Study — ACTIVE_NOT_RECRUITING
• Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT) — ACTIVE_NOT_RECRUITING · PHASE3
• Immersive Virtual Reality Applied to Therapeutic Physical Exercise in Cellular Therapy — NOT_YET_RECRUITING · NA
• The Impact of the Practice of Touch-massage on the Anxiety of Patients With Hematological Disorders Hospitalized in a Protective Environment, a Randomized, Controlled Study — COMPLETED · NA
• Pacritinib With Aza for Upfront Myelodysplastic Syndrome — NOT_YET_RECRUITING · PHASE1
• Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger — COMPLETED
• Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response. — COMPLETED · PHASE2
• Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients — COMPLETED · PHASE2
• Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation — COMPLETED · NA
• Multimodal Sexual Dysfunction Intervention In HCT — COMPLETED · NA
• Clonal Hematopoiesis of Immunological Significance — NOT_YET_RECRUITING
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants — COMPLETED · PHASE1
• Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies — COMPLETED · PHASE1
• Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation — ACTIVE_NOT_RECRUITING · PHASE1
• Autologous Transplantation of Human Cryopreserved Testis Tissue — ACTIVE_NOT_RECRUITING · NA
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years — TERMINATED · PHASE1
• A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia — COMPLETED · PHASE2
• Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant — ACTIVE_NOT_RECRUITING
• Radiological Characterization of Pulmonary Involvement in Patients With Hematological Diseases — COMPLETED
• Cardiac Coherence Combined With Personal Physical Activity in Patients With Cancer — COMPLETED · NA
• Multiple Myeloma Prognostic Indices — COMPLETED
• The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) — WITHDRAWN · PHASE1
• Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation — COMPLETED · NA
• National Project on Vaccines, COVID-19 and Frail Patients — COMPLETED
• A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants — COMPLETED · NA
• Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS — COMPLETED · PHASE1

Refine this search